3/17
01:07 pm
iccm
IceCure Medical (ICCM) Q4 2025 Earnings Transcript [Yahoo! Finance]
Low
Report
IceCure Medical (ICCM) Q4 2025 Earnings Transcript [Yahoo! Finance]
3/17
12:49 pm
iccm
IceCure Medical Ltd (ICCM) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
IceCure Medical Ltd (ICCM) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/17
08:49 am
iccm
IceCure Reports 2025 Full Year Financial & Operational Results [Yahoo! Finance]
Medium
Report
IceCure Reports 2025 Full Year Financial & Operational Results [Yahoo! Finance]
3/17
08:30 am
iccm
IceCure Reports 2025 Full Year Financial & Operational Results
Medium
Report
IceCure Reports 2025 Full Year Financial & Operational Results
3/16
09:24 am
iccm
What To Expect From Icecure Medical Ltd (ICCM) Q4 2025 Earnings [Yahoo! Finance]
Medium
Report
What To Expect From Icecure Medical Ltd (ICCM) Q4 2025 Earnings [Yahoo! Finance]
3/11
08:49 am
iccm
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer [Yahoo! Finance]
Low
Report
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer [Yahoo! Finance]
3/11
08:30 am
iccm
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer
Medium
Report
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer
3/10
08:30 am
iccm
IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026
Low
Report
IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026
3/9
08:41 am
iccm
American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer [Yahoo! Finance]
Low
Report
American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer [Yahoo! Finance]
3/9
08:30 am
iccm
American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer
Low
Report
American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer
3/2
08:43 am
iccm
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas [Yahoo! Finance]
Low
Report
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas [Yahoo! Finance]
3/2
08:30 am
iccm
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas
Low
Report
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas
2/23
08:30 am
iccm
IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026
Low
Report
IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026
2/19
08:30 am
iccm
IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense®, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation
Low
Report
IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense®, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation
2/11
08:30 am
iccm
IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense®
Low
Report
IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense®
2/9
04:44 pm
iccm
IceCure CFO Ronen Tsimerman to depart [Seeking Alpha]
Low
Report
IceCure CFO Ronen Tsimerman to depart [Seeking Alpha]
2/9
04:30 pm
iccm
IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved
Low
Report
IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved
2/7
02:07 am
iccm
IceCure Medical (NASDAQ:ICCM) was upgraded by analysts at
Wall Street Ze
Low
Report
IceCure Medical (NASDAQ:ICCM) was upgraded by analysts at
Wall Street Ze
1/28
08:42 am
iccm
IceCure Celebrates American Society of Breast Surgeons' (ASBrS) Proposed Breast Cancer Treatment Guidelines Which Include Cryoablation for Low-Risk Breast Cancer [Yahoo! Finance]
Low
Report
IceCure Celebrates American Society of Breast Surgeons' (ASBrS) Proposed Breast Cancer Treatment Guidelines Which Include Cryoablation for Low-Risk Breast Cancer [Yahoo! Finance]
1/28
08:30 am
iccm
IceCure Celebrates American Society of Breast Surgeons' (ASBrS) Proposed Breast Cancer Treatment Guidelines Which Include Cryoablation for Low-Risk Breast Cancer
Medium
Report
IceCure Celebrates American Society of Breast Surgeons' (ASBrS) Proposed Breast Cancer Treatment Guidelines Which Include Cryoablation for Low-Risk Breast Cancer
1/24
05:08 am
iccm
IceCure Medical (NASDAQ:ICCM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
IceCure Medical (NASDAQ:ICCM) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
1/15
06:21 am
iccm
When Will IceCure Medical Ltd (NASDAQ:ICCM) Turn A Profit? [Yahoo! Finance]
Low
Report
When Will IceCure Medical Ltd (NASDAQ:ICCM) Turn A Profit? [Yahoo! Finance]
1/12
08:51 am
iccm
IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense® Sales [Yahoo! Finance]
Medium
Report
IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense® Sales [Yahoo! Finance]
1/12
08:30 am
iccm
IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense® Sales
Medium
Report
IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense® Sales